Movement Alert|Centene Rises 5.03% in Regular Trading, Multiple Analyst Target Price Upgrades Boost Sentiment

Market Focus
06/09

On June 9, Centene rose 5.03% in regular trading, trading at $65.457/share, with trading volume of $288 million. The rally comes amid a wave of analyst target price upgrades over recent sessions.

JPMorgan raised its target price on Centene from $52 to $60 on June 8 while maintaining a Neutral rating. Earlier, Truist lifted its target from $58 to $71 on June 1 with a Buy rating, and Morgan Stanley raised its target from $50 to $57 on June 4, maintaining an Equal Weight rating. The consensus mean target price among analysts polled stands at approximately $60, with an average Overweight rating.

Within the Managed Health Care sector, peer stocks also showed broad strength. Among individual stocks, Molina Healthcare up 3.67%, UnitedHealth up 1.78%, Humana up 1.04%, Elevance Health up 0.29%, while HealthEquity down 0.37%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10